(Q73311867)

English

Post-remission therapy of adult acute myeloid leukaemia: one cycle of high-dose versus standard-dose cytarabine. Leukaemia Project Group of the Swiss Group for Clinical Cancer Research (SAKK)

scientific article published on 01 March 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9137794%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Post-remission therapy of adult acute myeloid leukaemia: one cycle of high-dose versus standard-dose cytarabine. Leukaemia Project Group of the Swiss Group for Clinical Cancer Research (SAKK) (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9137794%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

4

object named as

F Cavalli

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9137794%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

M Fopp

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9137794%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M F Fey

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9137794%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M Bacchi

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9137794%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J Gmuer

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9137794%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

E Jacky

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9137794%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

L Schmid

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9137794%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A Tichelli

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9137794%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A Tobler

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9137794%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

L Tschopp

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9137794%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

V Von Fliedner

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9137794%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A Gratwohl

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9137794%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 March 1997

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9137794%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Annals of Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9137794%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9137794%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9137794%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

251-257

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9137794%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

High remission-induction rate in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008267904952

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term treatment for acute myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008267904952

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of acute myelocytic leukemia in patients 30 years of age and younger

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008267904952

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute myelogenous leukaemia: maintenance chemotherapy after early consolidation treatment does not prolong survival

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008267904952

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008267904952

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved survival for patients with acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008267904952

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008267904952

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and clinical cross-resistance of a new combination therapy (AMSA/VP16) in previously treated patients with acute nonlymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008267904952

7 January 2021

based on heuristic

inferred from DOI database lookup

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008267904952

7 January 2021

based on heuristic

inferred from DOI database lookup

Confidence intervals for reporting results of clinical trials

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008267904952

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008267904952

7 January 2021

based on heuristic

inferred from DOI database lookup

A linear rank test for use when the main interest is in differences in cure rates

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008267904952

7 January 2021

based on heuristic

inferred from DOI database lookup

Postremission chemotherapy for adults with acute myelogenous leukemia: improved survival with high-dose cytarabine and daunorubicin consolidation treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008267904952

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008267904952

7 January 2021

based on heuristic

inferred from DOI database lookup

Double intensive consolidation chemotherapy in adult acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008267904952

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008267904952

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008267904952

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008267904952

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9137794%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9137794%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73311867&oldid=1944789581"